Evaluation of the updated ABC-AF-bleeding score 2.0 in patients with atrial fibrillation treated with a direct oral anticoagulant or warfarin
The updated ABC-AF-bleeding score 2.0 provided better discrimination and calibration for the risk of major bleeding than clinical risk scores, which was consistent across multiple subgroups. These findings support the utility of the ABC-AF-bleeding score for advancing precision medicine in AF.
Authors
- Anthony Carnicelli (ORCID: https://orcid.org/0000-0002-9805-4562)
- Ziad M. Hijazi
- David D. Berg (ORCID: https://orcid.org/0000-0002-0366-5492)
- Alexander P. Benz (ORCID: https://orcid.org/0000-0003-2555-1266)
- J. Oldgren
- Christian T. Ruff
- Johan Lindbäck
- John H. Alexander
- David A. Morrow
- Agneta Siegbahn
- John W. Eikelboom
- Christopher B. Granger
- Robert P. Giugliano
- Renato D. Lopes
- Lars Wallentin
Institutions
- Uppsala University (SE)
- Tokai University (JP)
- Uppsala University Hospital (SE)
- Medical University of South Carolina (US)
- Johannes Gutenberg University Mainz (DE)
- Population Health Research Institute (CA)
- Clinical Research Institute (US)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Thrombolysis in Myocardial Infarction Study Group (US)
Publication Details
- Journal
- Journal of Thrombosis and Haemostasis
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.jtha.2025.09.032
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 30.07
Funders
- Bristol-Myers Squibb
- Pfizer
- Daiichi-Sankyo